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Abstract Pancreas transplantation is a surgical treatment
for diabetes mellitus. More than 23,000 pancreas trans-
plants have now been reported to the International
Transplant Registry (IPTR). Early diagnosis and therapy
for graft-related complications are essential for graft
survival. Radiologists must therefore understand the surgi-
cal procedure and the potential complications. During the
course of this review, we will illustrate the normal post-
operative anatomy and the imaging appearances of com-
mon potential complications.
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Introduction
Pancreas transplantation is a surgical treatment for diabetes
mellitus (DM). Most recipients have type 1 DM but 7.7%
have type 2 DM [1, 2]. Transplant obviates the need for
insulin treatment and is associated with an improvement in
quality of life and life expectancy. The euglycaemia
obtained has been shown to prevent and sometimes
improve the secondary complications of DM including
nephropathy, neuropathy, retinopathy and macrovascular
disease.
The first whole-pancreas transplant was performed in the
University of Minnesota, USA in 1966 [3] and, with
improvements in surgical technique and immunosuppres-
sive therapy, increasing numbers of successful transplants
are performed. More than 23,000 pancreas transplants have
now been reported to the International Transplant Registry
(IPTR) [1]. In the UK the number of pancreas transplants
has steadily increased from 30, in 1998-1999, to 209, in
2007-2008.
Following pancreas transplantation, it is essential that
any graft-related complications are diagnosed early to
ensure prompt treatment and optimal survival of both graft
and patient. In order to successfully interpret the imaging, it
is essential that the surgical procedure, normal post-
operative appearances and potential complications are
understood by the reporting radiologists. The clinically
suspected complication should direct the imaging modality
to be employed. In particular, the most appropriate CT
protocols should be utilised to ensure that the maximum
information is obtained at the lowest possible radiation
dose. Within this review we will illustrate the normal post-
operative anatomy and the imaging appearances of the
commonest potential complications.
Types of pancreas transplant
Pancreas transplantation is most commonly performed in
conjunction with a kidney transplant, a procedure referred
to as simultaneous pancreas-kidney (SPK) transplantation.
SPK transplants are considered in patients with insulin-
dependent DM and chronic renal failure either requiring or
F. A. Hampson (*): S. J. Freeman: A. S. Shaw
Department of Radiology, Addenbrooke’s Hospital,
Hills Road,
Cambridge CB2 0QQ, UK
e-mail: frances.hampson@addenbrookes.nhs.uk
J. Ertner:A. Butler: C. J. Watson
Department of Surgery, Addenbrooke’s Hospital,
Cambridge, UK
M. Drage
Department of Transplantation, Guy’s and St Thomas’ NHS Trust,
London, UK
Insights Imaging (2010) 1:339–347
DOI 10.1007/s13244-010-0046-3imminently requiring dialysis. SPK recipients have im-
proved 10-year survival when compared with diabetic
patients receiving kidney transplantation alone: mean
23.4 years versus 12.9 years, respectively [4].
Of 209 pancreas transplants performed in the UK in
2007-2008, 173 (83%) were SPK transplants donated
following brain death (DBD), although an increasing
number of pancreases in the UK are donated following
cardiac death (DCD). Alternatively, solitary pancreas trans-
plants may be performed [5], usually in patients who have
already had a kidney transplant often from a living donor:
so-called pancreas after kidney transplants (PAK). Approx-
imately 10% of cases involve PAKs. Occasionally, both
organs (distal pancreas segment and whole kidney) may
come from a living donor [6]. Only 0.5% pancreatic
transplants are from living donors [1].
Less than 10% involve pancreas transplantation alone
(PTA). Thirty percent of those given a PTA will eventually
need a renal transplant because of the adverse cumulative
effects of immunosuppression with calcineurin inhibitors
[7]. PTA is performed for patients with labile, poorly
controlled insulin-dependent type 1 DM with stable renal
function. The principal indication for a PTA is life-
threatening hypoglycaemic unawareness. The long-term
advantages of good glycaemic control must be weighed
against the risks of major surgery and the complications of
long-term immunosuppressive therapy.
Surgical technique
At our institution, the pancreas transplant is placed intra-
peritoneally, lying on the right side of the pelvis; the kidney
is placed in the left iliac fossa and is extra peritoneal to
facilitate biopsy (Fig. 1).
The donor pancreas is retrieved en bloc with the
duodenum, which is transected and stapled proximally just
beyond the pylorus and distally in the third part of the
duodenum. The common bile duct is also divided and
ligated at the level of the duodenum. At the recipient
hospital the donor iliac artery bifurcation is anastomosed to
the stumps of the splenic and superior mesenteric arteries of
the pancreas bloc; this facilitates implantation, during
which the donor common iliac artery is anastomosed to
the recipient artery, usually the common iliac in our centre;
thus the donor iliac artery forms an inverted Y-graft
conduit.
Venous outflow is via the donor portal vein, which is
anastomosed end-to-side to the recipient inferior vena cava;
in some centres the pancreas is implanted to the external
iliac vessels, in which case the portal vein may need to be
extended by anastomosing donor iliac vein to act as a
conduit. However, the use of venous extension grafts
increases the risk of graft thrombosis. A modification to
this technique is portal rather than systemic venous
drainage of the endocrine pancreas by anastomosing the
portal vein to the superior mesenteric vein.
Exocrine secretions drain via the donor duodenum,
which is nowadays commonly anastomosed to recipient
small bowel, either directly or, as in our centre, to a Roux
loop of recipient jejunum via a side-to-side anastomosis.
Alternatively, the donor duodenum may be anastomosed
directly to the bladder [8]. In all modifications the
recipient’s native pancreas is left untouched.
When both organs come from a living donor a distal
pancreatectomy is performed. The pancreas is divided at the
neck. Distally the main trunks of the splenic artery and vein
are divided proximal to the splenic branches. Proximally
the splenic artery is divided at its origin off the coeliac
trunk and the splenic vein is divided at the confluence with
the superior mesenteric vein. The donor splenic artery is
then anastomosed end to side to a recipient iliac artery and
the donor splenic vein is anastomosed end to side to a
recipient iliac vein. Exocrine secretions drain via an enteric
route or the bladder [6, 9, 10].
Imaging techniques and normal anatomy
Ultrasound (US), computed tomography (CT) and magnetic
resonance imaging (MRI) are all used to assess the pancreas
following transplantation. Conventional angiography is
largely reserved to confirm vascular complications and
permits endovascular therapy.
Fig. 1 Schematic diagram of SPK transplant, with enteric drainage
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pancreatic parenchyma, as the transplant margins are often
poorly defined. In addition, views may be limited by
overlying bowel gas due to the intra-peritoneal position of
the transplant pancreas. Assuming good views are obtained,
Doppler US may be of great use in evaluating the patency
and calibre of the arterial and venous grafts (Fig. 2). The
resistive index has been shown to be an unreliable indicator
of rejection and therefore biopsy is the diagnostic “gold
standard” [11, 12]. US-guided biopsies have a high success
rate [13], ensuring the modality’s continued application in
this field. There is, however, an increased risk of bleeding
associated with pancreas biopsy compared with transplant
kidney biopsy as the pancreas is intraperitoneal, thus
bleeding will not be tamponaded by either the peritoneum
or by the organ capsule. Pancreatic leaks are the other
complication which deters clinicians, and for these reasons
biopsy of the renal transplant may be used as a surrogate
marker for pancreatic rejection [14], although asynchronous
rejection may occur.
Complete and reliable evaluation of the pancreatic
parenchyma and the vascular and enteric anastomoses is
best achieved with cross-sectional imaging. Both CT and
MRI have their individual merits in this situation; CT is
often more readily available and permits images to be
acquired much more quickly than MRI. This is particularly
of value in unstable patients.
CT images should be acquired in three phases: unen-
hanced, arterial and venous. The unenhanced images are
used to locate the pancreas transplant and to identify
vascular thromboses and haematomas, due to their in-
creased attenuation. The arterial-phase study should be
performed in an early angiographic phase, focused on the
pancreas transplant. In our institution this is achieved by
bolus tracking over the abdominal aorta and imaging at 7s
after the arrival of contrast medium. The arterial phase
often demonstrates parenchymal enhancement and early
venous drainage, depending on the transit time across the
graft pancreas. The venous phase obtained 50s post-
injection (Fig. 3) of the whole abdomen and pelvis
demonstrates graft venous drainage, parenchymal enhance-
ment and fluid collections. Multi-detector CT (MDCT)
enables 3D reconstructions (Fig. 4) of the vascular
structures, which may enhance the detection of vascular
complications.
SPK transplants may result in asymmetrical enhance-
ment of the common iliac veins. This appearance is known
as pseudothrombosis of the iliac vein [15]. It results from
the rapid transit time across the transplant kidney and early
opacification of the iliac vein in comparison with the
contralateral side.
Dynamic contrast enhanced MRI allows superior evalu-
ation of the pancreatic parenchyma. Graft perfusion may be
assessed and areas of necrosis demonstrated. Evaluation of
the enteric anastomoses may be more difficult. MR
angiography is considered to be inferior to CT angiography
because of its limited spatial resolution.
MR cholangiopancreatography (MRCP) may be used to
detect duct abnormalities. In cases of recurrent graft
pancreatitis it can reveal both causes and consequences,
e.g. pancreatic necrosis. Collections resulting from pancre-
atic leaks may be also demonstrated. Secretin-augmented
MRCP has been used to show reduced exocrine function
that may correlate with pancreatic rejection [16].
One factor that may limit the application of both CT and
MRI is impaired renal transplant function, which is not
uncommon in the immediate post-operative period. Under
these circumstances both intravenous iodinated contrast
media and gadolinium-based contrast media should be used
with caution because of the respective risks of contrast-
induced nephropathy and nephrogenic systemic fibrosis.
Both CT and MRI may be applied without contrast media,
Fig. 2 US image revealing normal homogeneous echotexture of the
pancreatic graft (white asterisk) in the right iliac fossa, with normal
vascularity on power Doppler
Fig. 3 Coronal multiplanar reformat of SPK transplant, in the portal
venous phase of enhancement. Duodenal staple line (black arrows),
ureteric stent (grey arrow), renal (grey asterisk) and pancreatic
transplant (white asterisk), donor portal vein anastomosed to IVC
(black asterisk), splenic artery (white arrow)
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modality could be used if a pseudocyst or collection is
suspected.
Complications
Rejection is a common cause of pancreatic graft failure
[17]. For the period 2000-2004, the IPTR reported acute
rejection to be the cause of graft failure in 7-25% of cases.
Chronic rejection was reported to be the cause of graft
failure in 2-33% of cases [18]. Rejection has no specific
imaging features. The cause of early graft failure is often
difficult to determine clinically. Imaging therefore has a
vital role in the exclusion of other causes of pancreatic graft
failure and in guiding biopsy (Fig. 5).
The potential complications of pancreas transplant may
be divided into three categories: those related to the vessels,
those related to the graft parenchyma and those related to
the enteric anastomoses.
Pancreas graft vascular complications
Graft thrombosis is the most common non-immunological
cause of early graft failure. The incidence of graft
thrombosis has been reported to range from 2 to 19%
[19–26]. Venous thrombosis is more common than arterial
thrombosis [27–29].
In venous thrombosis, US Doppler imaging demon-
strates absent venous flow, and a high resistance arterial
waveform, with reversed diastolic flow, may also be seen
occasionally. Unenhanced CT may show thrombus as a
high attenuation portal vein or splenic vein (Fig. 6a). A
filling defect may be seen following the adminstration of
intravenous contrast medium (Fig. 6b); but subtle throm-
boses may be obscured following parenchymal enhance-
ment. Side-branch venous thromboses may be seen where
small venous side branches have been ligated during
retrieval. These are commonly of no clinical significance
but are monitored to exclude the presence of thrombus
propagation. Venous-graft thrombosis may result in pan-
creatic necrosis or duodenal stump breakdown, which
usually necessitates graft pancreatectomy. Prompt diagnosis
and immediate thrombectomy may be successful.
Graft arterial thrombosis is much less common than
venous thrombosis, and can occur in the early or late phase
post-transplantation. The thrombosis may also be seen as a
hyperdense vessel on unenhanced CT, with subsequent
non-enhancement following intravenous contrast medium
(Fig. 7). Early arterial thrombosis may occur spontaneously
at any of the anastomotic sites, or as a consequence of
vascular rejection, and results in non-enhancement and
subsequent necrosis of the pancreatic graft. Late arterial
occlusion may represent the end point of graft rejection.
This initially involves the smaller vessels and progresses to
involve the larger ones [30].
Emphysematous transformation may occur within a
necrotic graft. This is demonstrated on CT as gas locules
within the pancreatic graft [31]. It is impossible to
differentiate between emphysematous transformation and
gas-forming infection on CT. Scintigraphy with
radioisotope-labelled white blood cells may be used as a
suitable non invasive alternative, where there is clinical
uncertainty regarding the presence of graft associated
infection (Fig. 8). However, in this situation, surgical graft
exploration is usually indicated.
Haemorrhage may result from failure of the arterial
anastomoses, but more commonly occurs where the
superior mesenteric vessels or splenic vessels have been
ligated. A haematoma may be demonstrated as a high
attenuation collection on an initial unenhanced CT series.
Fig. 5 CT-guided biopsy of pancreatic transplant (white asterisk).
Renal transplant seen in left iliac fossa
Fig. 4 CT arteriogram demonstrating the ‘Y graft’ (white asterisk)o f
the donor splenic artery and SMA anastomosed to donor iliac artery
bifurcation (white arrow), which is in turn anastomosed to the
recipient external iliac artery (white arrowhead)
342 Insights Imaging (2010) 1:339–347Contrast extravasation may then be detected in the arterial
and/or venous phases. While significant intra–abdominal
bleeding after pancreas transplantation remains one of the
most common reasons for relaparotomy, less than 0.3% of
all pancreas grafts are lost as a result of haemorrhage [32].
Pseudoaneurysms, arteriovenous fistulae, arterial dis-
section and arterial stenosis represent some rarer vascular
complications. Pseudoaneurysms may be the result of
surgical technique (particularly if the mesenteric pedicle
has been divided with a linear stapling device), infection,
severe pancreatitis, or allograft biopsy. Arteriovenous
fistulae may be the result of vascular injury, either at
surgery or post-biopsy; they are common in the stapled
edge of the mesentery where the superior mesenteric
vessels have been divided. Arterial stenosis can arise at
any anastomosis and may ultimately lead to reduced
graft perfusion (Fig. 9). Occasionally, the arterial “Y
graft” conduit may kink; this can result in significant
haemodynamic compromise and graft dysfunction. Fur-
thermore, the donor portal vein may appear kinked
proximal to the anastomosis with the recipient IVC. It is
yet to be determined whether this is clinically significant.
Our experience suggests that this does not cause graft
dysfunction.
CT angiography is the best tool in the initial assessment
of these vascular complications. Conventional angiography
is used to confirm vascular abnormalities which may then
be amenable to endovascular therapy.
Parenchymal complications
Pancreatic parenchymal graft complications are an im-
portant cause of morbidity in the early post-operative
period. These complications include acute rejection,
Fig. 8
111Indium-labelled white cell scintigraphy. Uptake of radio-
isotope is seen in the right iliac fossa (black arrow), within the
infected pancreatic graft
Fig. 7 Conventional angiogram confirming the presence of arterial
thrombosis within the pancreatic graft. Only a short segment of the
donor common iliac artery (black arrow) is patent
Fig. 6 a Unenhanced coronal
CT reformat demonstrating high
attenuation thrombus within the
donor splenic vein (white ar-
row). b CT in the portal venous
phase reveals a thrombus within
the donor splenic vein (white
arrow)
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abscess formation.
The exact incidence of post-transplant pancreatitis is
very difficult to determine because of the lack of a
universally accepted definition [33–35]. Prolonged hyper-
amylasaemia is seen early post transplant in up to 35% of
all recipients [33]. Unfortunately amylase and lipase levels
correlate poorly with the severity of graft pancreatitis [33],
making evaluation of the true incidence of graft pancreatitis
near impossible.
Early graft pancreatitis is often due to reperfusion injury
and usually involves the whole graft (Fig. 10). In the early
post-operative period, ill-defined fat planes around the
pancreatic graft are commonly seen. The graft may appear
as an enhancing ‘mass’ surrounded by an omental wrap in
the right iliac fossa. At an early stage it may be difficult to
distinguish radiologically between the appearance of the
normal post operative pancreatic graft and early graft
pancreatitis. Furthermore, focal oedema of the donor’s
mesenteric fat attached to the SMA stump, presumably
the result of donor lymphatic vessel ligation, should not be
misinterpreted as focal oedematous pancreatitis [36].
MDCT is valuable in evaluating the complications of
pancreatitis, such as parenchymal necrosis and abscess
formation. Collections may be amenable to image-guided
drainage to alleviate the pressure effect on the vascular
supply and drainage of the pancreatic graft.
Repeated episodes of pancreatitis may be secondary to
ampullary or duodenal anastomotic stricture or mucus
plugging. MRCP may be of diagnostic use in this situation.
Mucus plugging may cause focal or generalised duct
dilatation, whereas an ampullary or anastomotic stricture
will result in generalised duct dilatation in the absence of a
pancreatic duct stricture. US can show a bulky pancreas,
possibly with associated fluid collections. However, inter-
pretation may be hampered by poorly defined pancreatic
margins. Both CT and US may be used to guide
percutaneous abscess drainage.
Pseudocysts form at a later stage as a result of graft
pancreatitis. They may occur inside or outside the graft and
have the potential to become infected. This may result in
Fig. 10 Axial CT image demonstrating a swollen pancreatic graft
(white asterisk), with marked peri-pancreatic fat stranding. Appear-
ances are consistent with graft pancreatitis
Fig. 9 a Conventional angio-
gram reveals a stenosis (black
arrow) within the ‘Y graft’, near
anastomoses with the donor
common iliac artery. b CT an-
giogram demonstrates stenosis
within the arterial supply (white
arrow)
Fig. 11 Conventional angiogram shows a small blush near the head
of the pancreatic graft, representing a pseudoaneurysm (white arrow)
344 Insights Imaging (2010) 1:339–347vascular pseudoaneurysm formation. The diagnosis should
be considered in patients with a pulsatile abdominal mass,
unexplained anaemia and/or haemodynamic instability, and
when there is rapid enlargement of a pseudocyst. CT
angiography is used to evaluate this possibility. Formal
angiography is subsequently used to confirm the presence
of a pseudoaneurysm (Fig. 11) and permit embolisation.
Another potential complication of pancreatitis is fistula
formation. Fistulae may form between the pancreatic graft
and the skin or the peritoneal cavity (Fig. 12). Sinus tracts
may also develop. Fistulae connecting to the skin are best
assessed with CT fistulograms. Internal fistulae are best
assessed with MRI.
Enteric complications
Thickening of the bowel loops surrounding the pancreas
graft frequently occurs in the post-operative period, often
due to manipulation during the surgical procedure, the
formation of a Roux loop and aggressive rehydration. This
usually resolves within 3–4 weeks. The donor duodenum
may also appear thick-walled [37].
Duodenal segment leaks may occur at the duodenojeju-
nostomy, but are more common at the staple line of the
duodenal stump (Fig. 13). These occur early due to
ischaemia, or late (>4 weeks) secondary to infection or
rejection. Free air around the graft is common in the early
post-operative period, but seen late may indicate an
anastomotic leak. Free fluid may also be seen and
collections may form adjacent to the leaking point.
Small bowel obstruction is most commonly secondary to
adhesions, a generic risk of abdominal surgery (Fig. 14).
Another potential cause is internal herniation of jejunal
loops posterior to the pancreatic graft, through a mesenteric
defect related to the Roux loop formation [37].
Complications of immunosuppressive therapy may man-
ifest in the bowel. Rarely, a neutropenic typhlitis may
develop. Alternatively, opportunistic infections with organ-
Fig. 13 Axial CT demonstrates a large collection (white asterisk)
posterior to the head of the pancreas graft (black asterisk) and donor
duodenal loop (white arrowhead). Surgical exploration confirmed a
leak at the donor duodenal staple line
Fig. 12 CT fistulogram reveals an entero-cutaneous fistula post-
pancreatitis. Contrast medium instilled via the cutaneous fistula
demarcates the fistulous tract (white arrows) to the pancreatic head
(black asterisk)
Fig. 14 Axial CT image on “lung windows” reveals extensive
pneumatosis coli, secondary to small bowel obstruction at the level
of the entero-enterostomy
Fig. 15 Axial CT image at the level of the atrophic native kidneys
demonstrates multiple soft tissue nodules (white arrows) within the
retroperitoneum and subcutaneous tissues. Biopsy confirmed post-
transplantation lymphoproliferative disorder
Insights Imaging (2010) 1:339–347 345isms such as cytomegalovirus, or antibiotic-associated
Clostridium difficile may cause colitis.
Complications secondary to immunosuppression
The common complications secondary to immunosuppres-
sion seen in solid organ transplantation are generally
categorised as related to either infection or tumour. We
would like to highlight the specific complication of post-
transplant lymphoproliferative disorder (PTLD) that can be
diagnosed using cross-sectional imaging. PTLD is a serious
but rare complication of pancreas transplantation. It has a
reported incidence after pancreatic transplantation of 3-12%
[38, 39]. It is associated with the higher levels of
immunosuppression needed in SPK transplants compared
with other solid organ transplants. It is associated with a
donor acquired EBV infection and is therefore commoner in
younger previously EBV-naive transplant recipients, for
example, type I DM recipients of SPK grafts. Diffuse
enlargement of the pancreatic graft is a common manifes-
tation, which is indistinguishable from oedematous pancre-
atitis or transplant rejection. Less commonly focal intra- or
extra-allograft masses may develop (Fig. 15), and lymph-
adenopathy and other organomegaly may also occur [40]. A
tissue diagnosis is essential as the treatment modalities
include a reduction in immunosuppression and consider-
ation of chemotherapy.
Conclusion
With the increasing number of pancreatic transplants that
are now being performed, it is vital that radiologists
understand the complex post-operative anatomy and the
potential complications of transplantation. By doing this,
they can use the diagnostic tools available to them to their
full potential. It is crucial that surgical and radiology teams
liaise in these patients, in order that the radiologists are
familiar with the local operative technique. This enables the
imaging to be tailored to the patient and will increase the
accuracy of image interpretation. In addition, by performing
percutaneous drainage procedures, biopsies and endovas-
cular therapies, radiologists have an important role to play
in the management of many complications.
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